Abstract:Macrocyclic peptides are predominantly peptide structures bearing one or more rings and spanning multiple amino acid residues. Macrocyclization has become a common approach for improving the pharmacological properties and bioactivity of peptides. A variety of ribosomal-derived and non-ribosomal synthesized cyclization approaches have been established. The biosynthesis of backbone macrocyclic peptides using seven new emerging methodologies will be discussed with regard to the features and strengths of each platform rather than medicinal chemistry tools. The mRNA display variant, known as the random nonstandard peptide integrated discovery (RaPID) platform, utilizes flexible in vitro translation (FIT) to access macrocyclic peptides containing nonproteinogenic amino acids (NAAs). As a new discovery approach, the ribosomally synthesized and post-translationally modified peptides (RiPPs) method involves the combination of ribosomal synthesis and the phage screening platform together with macrocyclization chemistries to generate libraries of macrocyclic peptides. Meanwhile, the split-intein circular ligation of peptides and proteins (SICLOPPS) approach relies on the in vivo production of macrocyclic peptides. In vitro and in vivo peptide library screening is discussed as an advanced strategy for cyclic peptide selection. Specifically, biosynthetic bicyclic peptides are highlighted as versatile and attractive modalities. Bicyclic peptides represent another type of promising therapeutics that allow for building blocks with a heterotrimeric conjugate to address intractable challenges and enable multimer complexes via linkers. Additionally, we discuss the cell-free chemoenzymatic synthesis of macrocyclic peptides with a non-ribosomal catalase known as the non-ribosomal synthetase (NRPS) and chemo-enzymatic approach, with recombinant thioesterase (TE) domains. Novel insights into the use of peptide library tools, activity-based two-hybrid screening, structure diversification, inclusion of NAAs, combinatorial libraries, expanding the toolbox for macrocyclic peptides, bicyclic peptides, chemoenzymatic strategies, and future perspectives are presented. This review highlights the broad spectrum of strategy classes, novel platforms, structure diversity, chemical space, and functionalities of macrocyclic peptides enabled by emerging biosynthetic platforms to achieve bioactivity and for therapeutic purposes.

Light-responsive bicyclic peptides

Quantum Confined Peptide Assemblies with Tunable Visible to Near-Infrared Spectral Range

Peptide Macrocyclization via Intramolecular Interception of Visible-Light-Mediated Desulfurization

Peptide Macrocyclisation via Intramolecular Interception of Visible-Light-Mediated Desulfurisation

Facile Multicomponent Polymerizations Toward Unconventional Luminescent Polymers with Readily Openable Small Heterocycles.

Cyclic arylopeptoid oligomers: synthesis and conformational propensities of peptide-mimetic aromatic macrocycles

Genetically Encoding Light‐Responsive Protein‐Polymers Using Translation Machinery for the Multi‐Site Incorporation of Photo‐Switchable Unnatural Amino Acids

Synthesis and Functionalization of Azetidine‐Containing Small Macrocyclic Peptides

Azobenzene-Based Macrocyclic Arenes: Synthesis, Crystal Structures, and Light-Controlled Molecular Encapsulation and Release

Construction of Cyclophane-Braced Peptide Macrocycles via Palladium-Catalyzed Picolinamide-Directed Intramolecular C(sp 2 )–H Arylation

P450-Catalyzed Biaryl Macrocyclization of Leaderless Ribosomal Peptides

Spiropyran‐Based Photoisomerizable α‐Amino Acid for Membrane‐Active Peptide Modification

Biosynthetic Strategies for Macrocyclic Peptides

Visible-Light-Mediated Macrocyclization for the Formation of Azetine-Based Dimers

Peptide Macrocyclization via Cu-catalyzed 1,3-Dipolar Cycloaddition of Azomethine Ylides

Chemically revertible molecular clasps: Hydroxamic acid-mediated peptide macrocyclization and linearization

Modular synthesis of clickable peptides via late-stage maleimidation on C(7)-H tryptophan

Employing unnatural promiscuity of sortase to construct peptide macrocycle libraries for ligand discovery

Synthesis of DNA-Encoded Macrocyclic Peptides via Visible-Light-Mediated Desulfurative C-C Bond Formation

Peptide/protein-based Macrocycles: from Biological Synthesis to Biomedical Applications

Visible Light-Controlled Intracellular Synthesis of Supramolecular Peptide Nanostructures